deepull, a developer of culture-free products for diagnosing sepsis and other acute infections, has appointed Didier Deltort to its board. Currently a senior advisor at Mérieux Equity Partners, Mr Deltort has 30 years’ experience in medical device and healthcare technology including senior positions at GE Healthcare, Boston Scientific, Zimmer Biomet and HP Inc. He holds a Masters in biomedical engineering from the Université de Technologie de Compiègne, France.
deepull announced the appointment on 22 May 2024
Copyright 2024 Evernow Publishing Ltd